Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells

References

• Li Y, Li G, Guo X, et al. Non-coding RNA in bladder cancer. Cancer Lett 2020;485:38–44.
   PubMed Web of Science ®Google Scholar
• Xu X, Liu K, Jiao B, et al. Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer. J Control Release 2020;324:493–504.
   PubMed Web of Science ®Google Scholar
• Zhang M, Du H, Wang L, et al. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. Chem Biol Interact 2020;320:109022.
   PubMed Web of Science ®Google Scholar
• Shi YX, He YJ, Zhou Y, et al. LSD1 negatively regulates autophagy in myoblast cells by driving PTEN degradation. Biochem Biophys Res Commun 2020;522:924–30.
   PubMed Web of Science ®Google Scholar
• Li ZR, Suo FZ, Guo YJ, et al. Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation. Bioorg Chem 2020;97:103648.
   PubMed Web of Science ®Google Scholar
• Egolf S, Aubert Y, Doepner M, et al. LSD1 inhibition promotes epithelial differentiation through derepression of fate-determining transcription factors. Cell Rep 2019;28:1981–92.e7.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang C, Zhang X, et al. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors. Eur J Med Chem 2020;194:112243.
   PubMed Web of Science ®Google Scholar
• Liu HM, Suo FZ, Li XB, et al. Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors. Eur J Med Chem 2019;175:357–72.
   PubMed Web of Science ®Google Scholar
• Chen Y, Kim J, Zhang R, et al. Histone demethylase LSD1 promotes adipocyte differentiation through repressing Wnt signaling. Cell Chem Biol 2016;23:1228–40.
   PubMed Web of Science ®Google Scholar
• Ota Y, Miyamura S, Araki M, et al. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Bioorg Med Chem 2018;26:775–85.
   PubMedGoogle Scholar
• Karakaidos P, Verigos J, Magklara A. LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target. Cancers 2019;11:1821.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu Y, Sun l, et al. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents. Eur J Med Chem 2020;191:112181.
   PubMed Web of Science ®Google Scholar
• Azevedo-Barbosa H, Ferreira-Silva GÁ, Silva CF, et al. Phenylpropanoid-based sulfonamide promotes cyclin D1 and cyclin E down-regulation and induces cell cycle arrest at G1/S transition in estrogen positive MCF-7 cell line. Toxicol in Vitro 2019;59:150–60.
   PubMed Web of Science ®Google Scholar
• Ilies MA, Vullo D, Pastorek J, et al. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. J Med Chem 2003;46:2187–96.
   PubMed Web of Science ®Google Scholar
• Owa T, Yoshino H, Okauchi T, et al. Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J Med Chem 1999;42:3789–99.
   PubMed Web of Science ®Google Scholar
• Zhang K, Ni Y, Chen J, et al. Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer. Bioorg Med Chem Lett 2019;29:1502–6.
   PubMed Web of Science ®Google Scholar
• Fu DJ, Liu JF, Zhao RH, et al. Design and antiproliferative evaluation of novel sulfanilamide derivatives as potential tubulin polymerization inhibitors. Molecules 2017;22:1470.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu X, Wang F, et al. Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer. Eur J Med Chem 2020;204:112643.
   PubMed Web of Science ®Google Scholar
• Quero J, Cabello S, Fuertes T, et al. Proteasome versus thioredoxin reductase competition as possible biological targets in antitumor mixed thiolate-dithiocarbamate gold(III) complexes. Inorg Chem 2018;57:10832–45.
   PubMed Web of Science ®Google Scholar
• Krstulović L, Stolić I, Jukić M, et al. New quinoline-arylamidine hybrids: synthesis, DNA/RNA binding and antitumor activity. Eur J Med Chem 2017;137:196–210.
   PubMed Web of Science ®Google Scholar
• Li S, Hu L, Li J, et al. Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents. Eur J Med Chem 2019;162:666–78.
   PubMed Web of Science ®Google Scholar
• Su T, Zhu J, Sun R, et al. Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents. Eur J Med Chem 2019;178:154–67.
   PubMed Web of Science ®Google Scholar
• Zheng YC, Duan YC, Ma JL, et al. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. J Med Chem 2013;56:8543–60.
   PubMed Web of Science ®Google Scholar
• Ye XW, Zheng YC, Duan YC, et al. Synthesis and biological evaluation of coumarin-1,2,3-triazole-dithiocarbamate hybrids as potent LSD1 inhibitors. MedChemComm 2014;5:650–4.
   Web of Science ®Google Scholar
• Claudio VJ, Amanda D, Vanderlan da Silva B, et al. Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 2007;14:1829–52.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao H, Hu X, et al. Antidiabetic effects of different polysaccharide fractions from Artemisia sphaerocephala Krasch seeds in db/db mice. Food Hydrocoll 2019;91:1–9.
   Web of Science ®Google Scholar
• Shen JK, Cote GM, Choy E, et al. Programmed cell death ligand 1 expression in osteosarcoma. Cancer Immunol Res 2014;2:690–8.
   PubMed Web of Science ®Google Scholar
• Maes T, Mascaró C, Tirapu I, et al. ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia. Cancer Cell 2018;33:495–511.
   PubMed Web of Science ®Google Scholar
• Wang Z, Long QY, Chen L, et al. Inhibition of H3K4 demethylation induces autophagy in cancer cell lines. Biochim Biophys Acta Mol Cell Res 2017;1864:2428.
   PubMed Web of Science ®Google Scholar